The CEU Cardenal Herrera University today celebrates a new edition of its veterinary traumatology course, which addresses the techniques of sports medicine that apply to veterinary medicine, such as arthroscopic and plasma treatments rich in growth factors. This course has been conducted with the collaboration with BBraun-Aesculap, Smith & Nephews, García Cugat Foundation with the Veterinary Clinical Hospital of the CEU Cardenal Herrera University.
Among the speakers, THE CEU-UCH counts one more year with the participation of Dr. Ramón Cugat, member of the Garcia Cugat Foundation, one of the main Spanish specialists in sports medicine and injuries of the musculoskeletal system, especially in the knee, which deals numerous cases of footballers and elite athletes at the Hospital Quirón in Barcelona, where he leads the Department of Orthopedic Surgery and Traumatology. In addition, Dr. Alejandró Tarragó (IWOT) has collaborated in this initiative with Doctors José Rial and José Altonaga, directors of the Spanish Society of Veterinary Arthroscopy (SEAPV)
Enriched Plasma Treatments (PRGF)
Cugat and Tarragó work not only in parallel in the use of arthroscopy, but also in the application of an even newer technique in traumatology: plasma treatments rich in growth factors and autologous stem cells Since 2003 both doctors applied the first injection of this type of plasma to their first patients in human and veterinary medicine respectively respectively , they have worked in collaboration with the Universities of Córdoba, Murcia and also with the CEU Cardenal Herrera University of Valencia, where two doctoral theses on these treatments have already been defended and there are six more research papers in preparation. “Today we only know ten percent of the possibilities of application of these treatments for tissue repair, ranging from osteoarthrotic and osteopathic problems, to muscle injuries, soft tissue healing, facial paralysis, etc. and that are even having applications in otitis or dermatology,” says Dr. Cugat and Tarragó. For its part, Tarragó emphasizes that the results obtained in animals are being as good as in humans. Plasma treatments rich in growth factors are one of the most active lines of research currently in human medicine, with significant public funding figures. Its application in veterinary medicine is, therefore, in the opinion of both, the area with the greatest prospects for the veterinary traumatology of the future. A subject that will continue to focus the courses taught at the Clinical Veterinary Hospital of the CEU-UCH in Valencia, according to its director, Dr. Rafael Mazo.